Abstract: Provided by the present invention are novel compositions and methods for obtaining concentrated preparations of factor IX and formulations of factor IX suitable for storage and administration.
Abstract: IL-6 is produced via recombinant DNA techniques. The peptide is useful in the treatment of disorders characterized by deficiencies in hematopoietic cells and in combination with other hematopoietins in cancer therapies.
Type:
Grant
Filed:
June 17, 1991
Date of Patent:
February 19, 2002
Assignee:
Genetics Institute, Inc.
Inventors:
Steven C. Clark, Gordon G. Wong, Paul Schendel, John McCoy